article Open Access
Prudent use of NSAIDs in patients with COVID-19, Dengue, and Chikungunya
International Journal of Pharmaceutical and Clinical Research · 2023 · Vol. 5(1) · pp. 01–03
Abstract
NSAIDs are most common pharmacological options for pain management, although their use is questionable in many viral diseases like COVID-19, Dengue, and Chikungunya. Newer studies suggest to limit their use in such cases and also reinforces more careful considerations in patients with liver and kidney injuries or concurrent administration with other drugs/nutraceuticals such as antioxidants or SSRIs.
Drug-Induced Hepatotoxicity and ProtectionEpilepsy research and treatmentPharmacological Effects and Toxicity StudiesChikungunyaDengue feverCoronavirus disease 2019 (COVID-19)MedicineIntensive care medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)NutraceuticalVirologyInternal medicine
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
2%
vs. same field & year
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.